Connect with us

Health & Wellness

How to Ensure that your Teen Driver Learns the Principles of Safe Driving

Published

on

If your teenager is now eligible to apply for a provisional licence, it’s natural that you would have mixed emotions about this major milestone. Parents should feel excited to see their children growing up and getting prepared to take on the responsibilities of adulthood. But it’s not uncommon to feel worried that their teens will not view driver safety with the seriousness it deserves. Make clear to your teen that the privilege of driving demands adhering to safe driving principles. Here are ways to drive that point home.

Set a Good Example

It may seem that teenagers are always ready to start an argument or rebel against their parents’ wishes, but they still look to their mum and dad for cues about how to “adult” properly. You have an excellent opportunity to set a good example every time your teen is a passenger in your car.

Let your teen see how careful you are about maintaining distance between cars, the proper way to use mirrors, how you always use your turn signals, and that you drive at or below the speed limit. Most important, do not use your mobile phone while driving, even if you have the option to for hands-free use. Emphasize that any distraction from driving could quickly lead to an accident.

Explain that Driving Has Both Benefits and Risks

You may be tempted to focus only on the risks of driving because that is what most concerns you. But this kind of one-sided discussion could backfire if it appears you’re just trying to lecture your teen. Teenagers may get the impression that you don’t trust them or lack confidence in their abilities.

The better way to frame your conversations is to first bring up the benefits of driving and the freedoms that privilege entails. Emphasize that you’re so proud of them for learning what all drivers need to know to keep themselves and other drivers safe. But also stress that all drivers must practice responsible driving if they wish to hold on to their licence. By referring to all drivers, it will look less like an admonishment and more like a plain fact about privilege and responsibility.

Enroll Your Teen in a Reputable Driver’s Education Course

The material presented in any good driver’s education course will include:

  • A comprehensive overview of the current road rules, including when to give the right of way to pedestrians
  • Instructions for how to perform specific actions while driving (such as how to switch lanes, use a parking brake, and master skills like parallel parking)
  • How to navigate hazardous road conditions
  • Proper ways to handle an emergency

Besides learning what’s necessary to pass the driving theory test, student drivers typically spend between 45-50 hours learning how to drive and around 22 hours practicing. A certified driving instructor will hold either a green or a pink licence. The green licence indicates that the instructor has passed all of the Driver and Vehicles Standards Agency (DVSA) exams. While instructors who hold the pink license have not yet passed all three of the exams, they are still considered qualified to teach, as they are currently in training and simply have fewer hours of teaching experience.

Prior to 2015, practicing student drivers were not allowed on the motorways, but now it’s permitted. It’s beneficial to learn how driving on motorways is different from driving on other kinds of roadways, so it’s an advantage to new drivers that the law was passed.

Safe Driving Means More Than Just Passing Tests

Teens are in school full-time and have probably developed specific strategies for taking tests. If those strategies involve cramming the night before and memorizing a list of facts, they may pass, but are they really in full-possession of the knowledge required for safe driving?

You could probably easily convince your teen that they should not study for a calculus exam the same way they study for the driving theory test. Teens may not ever need to use calculus in the real world, but they will certainly be tested every time they get behind the wheel. The results of that test could have enormous life-or-death consequences. Teens must see the value in really understanding driving rules and recognize that only practice will help them become safe drivers.

Make Sure Your Teen Has Access to Up-To-Date Study Resources

Years ago, the only way to learn how to drive was to sign up for classroom instruction. The teacher would lecture and deliver the lessons about road rules and safe driving practices and then venture out on the road with the student to practice driving skills.

Classroom driver’s ed instruction can be valuable if the teacher is experienced in teaching the subject and can interact one-on-one with the students during class. But that’s not often the case. Classrooms may be crowded and distracting for students, the sessions may be held at inconvenient times, and the material itself may be dry and boring.

Today, students have the opportunity to study for their driving theory exam using a mobile app. These app courses are generally less expensive than classroom instruction, and offer a more personalized approach to learning the material. They allow students to learn at their own pace and highlight the areas where students need to pay more attention to the lesson.

Mobile driver’s education courses are also more fun and entertaining than what is offered in the classroom. The driver’s education app from Zutobi is built like a game, and students can earn points and badges to indicate their progress. They can also compete with their friends, which adds another level of motivation for learning. This gamified approach works to make students more engaged in the learning process. While they’re having fun, they’re also discovering the correct ways to use traffic signals, how to respond when they see less common road signs, and the tips they’ll need to pass the practical driving test.

Ensure Your Teen Has Enough Time To Learn and Absorb the Material

Sure, you are excited about your teen finally earning a licence, but there’s a high probability your new student driver feels the excitement tenfold! Because the DVSA issues only guidelines – not mandates – for how long it should take to learn to drive, teens are often anxious to hit the road directly after they have their licence in hand.

Take control of the process early on by getting involved in finding the best method for learning the material. You can apply for a provisional driving licence a few months before your teen turns sixteen, and encourage study even before that birthday.

When looking for a driving instructor, ask other parents for recommendations. Make sure the lessons fit into your teen’s schedule so that he or she will not feel rushed while practicing. It may also be helpful to plan practice driving “appointments” on a calendar so that you are certain your teen will have as much driving experience as possible before taking the driving test.

You’ve Got This!

You may be nervous of the day your teen gets a provisional licence and starts driving, but there is plenty you can do to prepare. Find the type of course that will best engage your teen, set a good example, be firm about following rules, and insist on an adequate number of practice hours. Taking these steps will help reduce your anxiety and make it easier for you to hand over the keys.

Tim Waldenback is the co-founder of Zutobi Drivers Ed, a gamified e-learning platform focused on online drivers education to help teens get their license. Tim founded Zutobi to make world-class driver's education fun, affordable, and easily accessible for all.

Continue Reading
Comments

Health & Wellness

COVID-19: WHO expresses hope worst of Omicron wave is over

Published

on

Omicron continues to sweep the world, but cases seem to have peaked in some countries, which gives the head of the World Health Organization (WHO) hope that the worst of this latest wave of COVID-19 is over. 

Briefing journalists in Geneva, Tedros Ghebreyesus said that more than 18 million cases were reported last week, and the pandemic itself is far from over, so no country is out of the woods yet.

The number of deaths remains stable, but the agency is concerned about the impact the variant is having on already exhausted health workers and overburdened health systems.

“I remain particularly concerned about many countries that have low vaccination rates, as people are many times more at risk of severe illness and death if they’re unvaccinated”, Tedros said. 

Omicron may be less severe, but for the WHO chief “the narrative that it is mild disease is misleading, hurts the overall response and costs more lives.”

Tedros noted that the virus is circulating “far too intensely with many still vulnerable” and argued that, for many countries, the next few weeks remain critical.

COVAX

Over the weekend, the UN-backed COVAX facility delivered its one-billionth dose of vaccine. 

Tedros said he was proud of the milestone, but believes it’s essential to keep forging ahead with distributing shots fairly, across the world. 

“Vaccines may be less effective at preventing infection and transmission of Omicron than they were for previous variants, but they still are exceptionally good at preventing serious disease and death”, he explained. 

For him, immunization continues to be “key to protecting hospitals from becoming overwhelmed.”

Tracking the virus

The WHO chief also highlighted the importance of tracking new variants, like Omicron, in real time.

Tedros believes that the pandemic is “nowhere near over” and, with the incredible growth of Omicron, new variants are likely to emerge

So far, more than 7 million whole genome sequences from 180 countries have been submitted to GISAID, a global mechanism that provides open access to genomic data and was initially set up to track flu.

Using all that data, new formulations of vaccines are being developed and assessed for how they perform against different strains. 

Despite those efforts, Tedros is concerned that the world will enter “a second and even more destructive phase of vaccine inequity”, if it doesn’t change course. 

New treatments 

Last Friday, WHO recommended two new COVID-19 treatmentsto fight severe illness and death: a rheumatoid arthritis drug called baricitinib and a monoclonal antibody called sotrovimab.

For Tedros, the challenge, once again, is that high prices and limited supply means access is limited.

WHO is currently working with its partners in ACT-Accelerator to negotiate lower prices with manufacturers and ensure supply will be available for low- and middle-income countries.

Meeting

Next week, the WHO Executive Board, which is made up of 34 Member States, will meet to discuss the world’s health challenges.

The pandemic will remain at the forefront, but Member States will also be discussing the devastating impact of the pandemic on other health issues, and how the backsliding can be stopped. 

According to the WHO chief, the agency willbe working to accelerate progress on negotiations around a global pandemic accord.

Cervical Cancer Awareness

On a final note, Tedros noted that January is Cervical Cancer Awareness month.

In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide and about 342, 000 women died from the disease.

The main cause of the disease is infection with high-risk types of human papillomavirus (HPV), an extremely common family of viruses that are transmitted through sexual contact.

There are, however, vaccines that protect against high-risk HPV types, which means it should be one of the most preventable and treatable forms of cancer.

On Monday, Serbia announced that this year,it will introduce a vaccination programme against HPV, joining the 116 nationswho already do it. 

Continue Reading

Health & Wellness

UN-backed COVAX mechanism delivers its 1 billionth COVID-19 vaccine dose

Published

on

photo © UNICEF/Aimable Twiringiyima

With a 1.1 million jab delivery in Rwanda this weekend, the World Health Organization’s multilateral initiative to provide equal access to vaccines for all reached the one billion milestone.

Along with the Coalition for Epidemic Preparedness Innovations (CEPI), the Vaccine Alliance GAVI, and partners, WHO has led the largest vaccine procurement and supply operation in history with deliveries to 144 countries to date.

According to a press release published on Sunday, as of 13 January 2022, out of 194 countries members of WHO, 36 have vaccinated less than 10% of their population, and 88 less than 40%.

COVAX’s ambition was compromised by hoarding/stockpiling in rich countries, catastrophic outbreaks leading to borders and supply being locked. And a lack of sharing of licenses, technology, and know-how by pharmaceutical companies meant manufacturing capacity went unused”, the agency explained.

On 24 February 2021, Ghana became the first country in the world to receive vaccines through COVAX when 600,000 doses of the Oxford–AstraZeneca vaccine were delivered to Accra. 

The work that remains

COVAX is currently working with governments, manufacturers and partners to ensure that when countries receive vaccines, they can get them to people quickly.

“The work that has gone into this (1 billion) milestone is only a reminder of the work that remains”, the UN’s health agency underscored.

They added that with updated vaccines in the pipeline, citizens should demand that governments and pharmaceutical companies share health tools globally and “bring an end to the death and destruction cycles of this pandemic, limit new variants and drive a global economic recovery”.

COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched by WHO in April 2020 in response to the pandemic.

The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. 

Continue Reading

Health & Wellness

WHO recommends two new drugs to treat patients with COVID-19 

Published

on

Around two million doses of Sotrovimab are being produced globally in the first half of 2022. © GlaxoSmithKline

The World Health Organization (WHO) on Thursday reccommended two new drugs to treat patients with COVID-19, one for patients with critical disease, and another deemed effective for non-severe cases.

The first drug, baricitinib, is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

According to the WHO Guideline Development Group, it is “strongly recommended” for patients with severe or critical disease in combination with corticosteroids.

The group of international experts based their recommendation on “moderate certainty evidence” that it improves survival and reduces the need for ventilation.

There was no observed increase in adverse effects.

The experts note that it has a similar effectas other arthritis drugs called interleukin-6 (IL-6) inhibitors. Because of that, when both drugs are available, they suggest choosing the best option based on cost, availability, and clinician experience.

It is not recommended to use both drugs at the same time.

The experts also advise against the use of two other JAK inhibitors (ruxolitinib and tofacitinib) for patients with severe or critical cases of COVID-19 infection.

According to them, trials undergone using these drugs failed to show any benefits arising using either drug,and suggested a possible increase in serious side effects with tofacitinib.

Non-severe cases

In the same update, WHO makes a conditional recommendation for the use of a monoclonal antibody known as sotrovimab in patients with non-severe cases.

According to them, the drug should only be administered to patients at the highest risk of hospitalisation. In those at lower risk, it onlyshowed “trivial benefits”. 

A similar recommendation has been madepreviously, for another monoclonal antibody drug, casirivimab-imdevimab, and the experts say there is insufficient data to recommend one over the other.

For both, the effectiveness against new variants, like Omicron, is still uncertain. 

The group will update their guidelines for monoclonal antibodies when more data becomes available.

Recommendations

These recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical infections.

Developed by WHO with the methodological support of MAGIC Evidence Ecosystem Foundation, the guidelinesprovide trustworthy guidance and help doctors make better decisions with their patients.

According to the agency, the guidelines are useful in fast moving research areas, because they allow researchers to update evidence summaries as new information becomes available.

The latest guidance also updates recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical COVID-19; conditional recommendations for the use of casirivimab-imdevimab (another monoclonal antibody treatment) in selected patients; and against the use of convalescent plasma, ivermectin and hydroxychloroquine, regardless of disease severity.

Continue Reading

Publications

Latest

East Asia58 mins ago

China and Indo-Pacific democracies in the face of American boycott of Beijing Winter Olympics

Despite the US administration’s announcement of a boycott of the Winter Olympics in Beijing, with the “American Olympic Committee allowing...

New Social Compact4 hours ago

E-resilience readiness for an inclusive digital society by 2030

The COVID-19 pandemic has clearly demonstrated the link between digitalization and development, both by showing the potential of digital solutions...

Tech News6 hours ago

Maintenance Tips for Second-Hand Cars

With a shortage of semiconductors continuing to plague the automotive industry, many are instead turning to the second-hand market to...

New Social Compact6 hours ago

Delivering on Our Promise for Universal Education

On the International Day of Education, we call on world leaders to transform how we deliver on education. The clock...

Africa Today8 hours ago

Bringing dry land in the Sahel back to life

Millions of hectares of farmland are lost to the desert each year in Africa’s Sahel region, but the UN Food...

Middle East10 hours ago

“Kurdish Spring”: drawing to a close?

For decades, the Kurdish problem was overshadowed by the Palestinian one, occasionally popping up in international media reports following the...

Central Asia12 hours ago

Great powers rivalry in Central Asia: New strategy, old game

In international politics, interstate rivalry involves conflicting relations between two international rivalries that are nation states. A fundamental feature of...

Trending